Drug Trial Radar · NCT05944224
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
63
Planned (sponsor's estimate)
Start
Oct 17, 2023
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Shanghai Pharmaceuticals Holding Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Jul 13, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, Open-label, Phase Ib/IIa study to evaluate the efficacy and safety of SPH4336 monotherapy or in combination with Cadonilimab in the patients with selected advanced solid tumors.
Conditions
- Advanced Solid Tumors
Interventions
SPH4336Drug
SPH4336 Tablets :Orally, 400mg once a day ; 28 days/cycle
CadonilimabDrug
Intravenous infusion, 6mg/Kg,28 days/cycle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS)Time frame: Approximately 2 years
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Peking Union Medical College Hospital
Beijing, China · Recruiting
Peking University People's Hospital
Beijing, China · Recruiting
Fudan University Shanghai Cancer Center
Shanghai, China · Recruiting
Shanghai Sixth People's Hospital
Shanghai, China · Recruiting
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China · Recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
The First Affiliated Hospital,Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
Henan Cancer Hospital
Zhengzhou, He'nan, China · Recruiting
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
Xiangya Hospital Central South University
Changsha, Hunan, China · Recruiting
The Central Hospital of Yongzhou
Yongzhou, Hunan, China · Recruiting
Liaoning Cancer Hospital & Institute
Shenzhen, Liaoning, China · Recruiting
Xijing Hospital
Xi’an, Shanxi, China · Recruiting
West China Hospital,Sichuan University
Chengdu, Sichuan, China · Recruiting
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Recruiting
Zhejiang cancer Hospital
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.